Seeing Is Believing
Healthcare - Sector
REPL is currently covered by 7 analysts with an average price target of $16.73. This is a potential upside of $6.55 (64.34%) from yesterday's end of day stock price of $10.18.
Replimune Group's activity chart (see below) currently has 106 price targets and 96 ratings on display. The stock rating distribution of REPL is 40.91% BUY, 40.91% HOLD and 18.18% SELL.
Analysts average stock forecasts to be materialized ratio is 37.07% with an average time for these price targets to be met of 185.82 days.
Highest price target for REPL is $18, Lowest price target is $3, average price target is $10.5.
Most recent stock forecast was given by EVAN SEIGERMAN from BMO on 03-Nov-2025. First documented stock forecast 14-Aug-2018.
Currently out of the existing stock ratings of REPL, 9 are a BUY (40.91%), 9 are a HOLD (40.91%), 4 are a SELL (18.18%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$11
$1 (10.00%)
$2
1 months 10 days ago
(03-Nov-2025)
0/6 (0%)
$1.27 (13.05%)
Hold
$12
$2 (20.00%)
1 months 16 days ago
(27-Oct-2025)
1/19 (5.26%)
$2.67 (28.62%)
22
Hold
$18
$8 (80.00%)
$4
1 months 23 days ago
(20-Oct-2025)
6/14 (42.86%)
$9.05 (101.12%)
191
Hold
$13
$3 (30.00%)
$3
1 months 23 days ago
(20-Oct-2025)
2/8 (25%)
$4.05 (45.25%)
341
Sell
1 months 23 days ago
(20-Oct-2025)
5/13 (38.46%)
$6.19 (220.28%)
390
What is REPL (Replimune Group) average time for price targets to be met?
Which analyst has the current highest performing score on REPL (Replimune Group) with a proven track record?
Which analyst has the most public recommendations on REPL (Replimune Group)?
Which analyst is the currently most bullish on REPL (Replimune Group)?
Which analyst is the currently most reserved on REPL (Replimune Group)?